BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20338599)

  • 1. [Severe ovarian hyperstimulation syndrome].
    Curiel Balsera E; Prieto Palomino MÁ; Muñoz Bono J; Banderas Bravo E
    Med Clin (Barc); 2011 Jul; 137(4):184-5. PubMed ID: 20338599
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the article "Severe ovarian hyperstimulation syndrome after exogenous administration of human chorionic gonadotropin].
    Pedroviejo Sáez V
    Rev Esp Anestesiol Reanim; 2010; 57(6):392-3. PubMed ID: 20645497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ovarian hyperstimulation syndrome: pathophysiology and systemic repercussions].
    Trillo Urrutia L; Gris Martínez JM
    Rev Esp Anestesiol Reanim; 2009 Nov; 56(9):525-6. PubMed ID: 20112541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe ovarian hyperstimulation syndrome after exogenous administration of human chorionic gonadotropin].
    Aznar Millán O; Ramos Aparici R; Campos Pérez J; Vila Sánchez M
    Rev Esp Anestesiol Reanim; 2009 Nov; 56(9):565-8. PubMed ID: 20112548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascites ultrafiltration and concentration-reinfusion in severe ovarian hyperstimulation syndrome.
    Liangfei A; Liangbin X; Wangming X; Jing Y
    Br J Hosp Med (Lond); 2011 Mar; 72(3):170-1. PubMed ID: 21475099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome.
    Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y
    Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The ovarian hyperstimulation syndrome in pregnancy after IVF-ET].
    Kozovski I; Markova V; Andonov M
    Akush Ginekol (Sofiia); 1998; 37(2):26-7. PubMed ID: 9859531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous ovarian hyperstimulation syndrome in a normal singleton pregnancy.
    Oztekin O; Soylu F; Tatli O
    Taiwan J Obstet Gynecol; 2006 Sep; 45(3):272-5. PubMed ID: 17175480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis and management of ovarian hyperstimulation syndrome.
    Shmorgun D; Claman P;
    J Obstet Gynaecol Can; 2011 Nov; 33(11):1156-1162. PubMed ID: 22082791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High interleukin 2 receptor levels in the pleural effusion of a patient with pulmonary manifestations of ovarian hyperstimulation syndrome.
    Fatum M; Abramov Y; Laufer N; Shushan A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):968-9. PubMed ID: 12455193
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ovarian hyperstimulation syndrome associated with spontaneous pregnancy: report of two cases].
    Xu HY; Fan SS; Li H
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1192-3. PubMed ID: 16273704
    [No Abstract]   [Full Text] [Related]  

  • 12. [Right-sided hydrothorax--the only sign of ovarian hyperstimulation syndrome].
    Mannheimer B; Wramsby M
    Lakartidningen; 2007 Jan 17-23; 104(3):132-3. PubMed ID: 17302118
    [No Abstract]   [Full Text] [Related]  

  • 13. Spontaneous severe ovarian hyperstimulation syndrome in successive pregnancies with successful outcomes.
    Lovgren TR; Tomich PG; Smith CV; Berg TG; Maclin V
    Obstet Gynecol; 2009 Feb; 113(2 Pt 2):493-495. PubMed ID: 19155932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe ovarian hyperstimulation syndrome and tubal pregnancy after in vitro fertilization].
    Nawroth F; Kissing K
    Zentralbl Gynakol; 1998; 120(7):347-9. PubMed ID: 9703658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome.
    Herrero L; Pareja S; Losada C; Cobo AC; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2011 Mar; 95(3):1137-40. PubMed ID: 21047635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated unilateral pleural effusion as the only manifestation of the ovarian hyperstimulation syndrome.
    Aldawood AS; Felemban AA
    Saudi Med J; 2003 Dec; 24(12):1397-9. PubMed ID: 14710293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian hyperstimulation syndrome during in vitro fertilization stimulations. Comparison between the experience of the Center for Medically Assisted Procreation of the Saint Antoine maternity department and a review of the literature].
    Guettier X; Larue L; Chamorand E; Barbier D; Jault T; Liou Y; Marpeau L; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(8):887-95. PubMed ID: 1491132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study.
    Courbiere B; Oborski V; Braunstein D; Desparoir A; Noizet A; Gamerre M
    Fertil Steril; 2011 Apr; 95(5):1629-32. PubMed ID: 21215968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late presentation with severe ovarian hyperstimulation syndrome is diagnostic of clinical in vitro fertilization pregnancy.
    Richter KS; Van Nest RL; Stillman RJ
    Fertil Steril; 2004 Aug; 82(2):478-9. PubMed ID: 15302307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.